Bloomberg Daybreak: Europe Edition Tariff Plans Still In Limbo, Markets Hold Their Breath & Big Pharma Fears
Apr 2, 2025
Naomi Kresge, a senior reporter at Bloomberg, dives into the pharmaceutical industry's rising fears over looming tariff announcements that could impact drug pricing and supply chains. Brendan Murray, a trades expert, shares insights on how these tariffs might reshape the market landscape. They discuss the unfolding uncertainty from the Trump administration's plans and the potential economic ripple effects, from rising costs to shifting global trade dynamics. The conversation sheds light on the nervous atmosphere as businesses brace for impact.
AI Snips
Chapters
Transcript
Episode notes
Trump's Tariff Options and Impacts
- Trump administration is considering different tariff structures including flat, tiered, and more targeted tariffs.
- The tariffs aim to reduce trade deficits and bring manufacturing jobs back to the U.S., impacting many global trading partners.
Federal Reserve's Tariff Concerns
- Tariffs could increase inflation and unemployment, complicating the Federal Reserve's monetary policy.
- A tariff-related slowdown in consumer spending or investment could disrupt economic growth.
UK Economic Risks From Tariffs
- The UK faces a potential 1.1% GDP drop if U.S. tariffs hit, cutting exports by 70%.
- UK officials are negotiating for exemptions, but initial tariffs may apply universally.